my account
log out
|
|
my account
log out
|
Anti-CD38 immunotoxin IB4 (IgG)-RTA |
| Create: 02/27/2017 |
| Expired Date: | 02/21/2020 |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | This immunotoxin was achieved by conjugating/fusing the Anti-CD38 monoclonal antibody to ricin toxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to CD38+ cells. Then the ricin A chain is incorporated into the cell by receptor-mediated endocytosis, blocking ribosomal protein synthesis and ultimately leading to cell death. It was designed for treatment of Non Hodgkin lymphoma (NHL). |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 214 | |
| Feb 01 2023 | GVBE Buffer | 214 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 208 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 392 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 476 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 385 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 401 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 387 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 411 |
| Copyright © toextrade Inc. All rights reserved. Contact us |